StockData
LB Pharmaceuticals Inc logo

LB Pharmaceuticals Inc (LBRX) stock

LBRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$40.30−2.69 (-6.26%)

Close on Nov 17, 2026Market cap $1.30BP/E –Yield –

LB Pharmaceuticals total assets

Total assets on the balance sheet at the end of each period.

LB Pharmaceuticals's total assets was $361.69M at Jun 30, 2026. For fiscal 2025 it was $312.93M, up 833.2% from the year before.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$312.93M+833.2%
FY2024Dec 31, 2024$33.53M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$361.69M+978.6%
Q1 FY2026Mar 31, 2026$393.48M–
Q4 FY2025Dec 31, 2025$312.93M–
Q3 FY2025Sep 30, 2025$320.75M–
Q4 FY2024Dec 31, 2024$33.53M–

More LB Pharmaceuticals figures

See a number that looks wrong?